Photophysical and Chiroptical Properties of the Enantiomers of ,'-Bis(1-phenylpropyl)-2,6-pyridinecarboxamide and their Chiral 9-Coordinate Ln Complexes.

Eur J Inorg Chem

V. Y. Chang, K. U. D. Calvinho, R. C. Tovar, V. A. Johnson, Prof. D. A. Straus, Prof. G. Muller Department of Chemistry, San José State University, One Washington Square, San José, CA, 95192-0101, USA.

Published: October 2020

The , and , enantiomers of ,'-bis(1-phenylpropyl)-2,6-pyridinedicarboxamide, , react with Ln ions (Ln = La, Eu, Gd, and Tb) to give stable [Ln((,)- and (,)-))] in anhydrous acetonitrile solution, as evidenced by various spectroscopic measurements, including NMR and luminescence titrations. In addition to the characteristic Eu and Tb luminescence bands, the steady-state and time-resolved luminescence spectra of the aforementioned complexes show the residual ligand-centered emission of the ππ* to ππ* states, indicating an incomplete intersystem crossing (ISC) transfer from the ππ* to ππ* and ligand-to-Ln energy transfer, respectively. The high circularly polarized luminescence (CPL) activity of [Eu()] confirms that using a single enantiomer of induces the preferential formation of one chiral [Eu()] complex, consistent with the [Eu ] complexes formed with other ligands derived from a 2,6-pyridine dicarboxamide moiety. Furthermore, the CPL sign patterns of complexes with (,) or (,) enantiomer of are consistent with the CPL sign pattern of related [Ln ] complexes with the (,) or (,) enantiomer of the respective ligands in this family.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640761PMC
http://dx.doi.org/10.1002/ejic.202000606DOI Listing

Publication Analysis

Top Keywords

ππ* ππ*
8
cpl sign
8
complexes enantiomer
8
complexes
5
photophysical chiroptical
4
chiroptical properties
4
properties enantiomers
4
enantiomers '-bis1-phenylpropyl-26-pyridinecarboxamide
4
'-bis1-phenylpropyl-26-pyridinecarboxamide chiral
4
chiral 9-coordinate
4

Similar Publications

PEX1 remains functional in peroxisome biogenesis but is rapidly degraded by the proteasome.

bioRxiv

December 2024

Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.

The PEX1/PEX6 AAA-ATPase is required for the biogenesis and maintenance of peroxisomes. Mutations in and disrupt peroxisomal matrix protein import and are the leading cause of Peroxisome Biogenesis Disorders (PBDs). The most common disease-causing mutation in PEX1 is the PEX1 allele, which results in a reduction of peroxisomal protein import.

View Article and Find Full Text PDF

WD repeat domain 74 (WDR74) is a nucleolar protein involved in the early stages of pre-60S maturation in the ribosome biogenesis pathway. In later stages, WDR74 interacts with MTR4, an RNA helicase that functions with the exosome nuclease complex, and is dissociated upon ATP hydrolysis by the chaperone-like nuclear VCP-like 2 (NVL2) AAA-ATPase. We previously reported that ATP hydrolysis-defective NVL2 causes aberrant accumulation of WDR74 on the MTR4-exosome complex at the nucleolar periphery and in the nucleoplasm and that this nuclear redistribution of WDR74 leads to the unusual cleavage of the early rRNA precursor within the internal transcribed spacer 1 sequence.

View Article and Find Full Text PDF

Evaluation of cephalosporin allergy: Survey of drug allergy experts.

J Allergy Clin Immunol Glob

February 2025

Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

Background: Since the publication of the 2022 Drug Allergy Practice Parameters (DAPP) of the American Academy of Allergy, Asthma & Immunology (AAAAI) and American College of Allergy, Asthma & Immunology (ACAAI), it is unclear the extent to which the simplified and risk-stratified evaluation of cephalosporin allergy has been incorporated into allergy practice.

Objective: We aimed to assess current cephalosporin allergy testing practices using real case examples.

Methods: An 18-question REDCap survey was sent to the 136 members of the Adverse Reactions to Drugs, Biologics and Latex (ARDBL) Committee of the AAAAI between February and April 2023.

View Article and Find Full Text PDF
Article Synopsis
  • Successful interspecies hybridization requires a stable "2n" chromosome set to produce viable "n" gametes, often achieved by doubling chromosome numbers or through rare recombination events.
  • In a study of third-generation hybrids resulting from a cross between Brassica juncea and B. napus, chromosome numbers varied significantly, indicating a complex genome structure influenced by unreduced gametes.
  • The research found a higher frequency of unreduced gametes in the hybrids compared to the parent species, suggesting this mechanism is crucial for stabilizing and increasing fertility in hybrid offspring.
View Article and Find Full Text PDF

Omalizumab was recently approved by the US Food and Drug Administration for treatment of any single food allergy or multiple food allergies in children aged 1 year and older and adults. There is currently no formal guidance regarding recommended best practices for omalizumab use in food allergy, including patient selection, anticipated goals and outcomes of therapy, procedure for monitoring patients who elect to start omalizumab therapy, and ways in which omalizumab can be incorporated into the landscape of food allergy management and daily clinical practice. This work group report was developed by the food allergy therapies subcommittee of the Adverse Reactions to Foods Committee within the American Academy of Allergy, Asthma & Immunology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!